Challenges in the Management of Patients with Chronic Obstructive Pulmonary Disease and Heart Failure With Reduced Ejection Fraction

Current Heart Failure Reports
Abhishek JaiswalThierry H Le Jemtel

Abstract

Chronic obstructive pulmonary disease (COPD) and heart failure with reduced ejection fraction (HFrEF) commonly coexist in clinical practice. The prevalence of COPD among HFrEF patients ranges from 20 to 32 %. On the other hand; HFrEF is prevalent in more than 20 % of COPD patients. With an aging population, the number of patients with coexisting COPD and HFrEF is on rise. Coexisting COPD and HFrEF presents a unique diagnostic and therapeutic clinical conundrum. Common symptoms shared by both conditions mask the early referral and detection of the other. Beta blockers (BB), angiotensin-converting enzyme inhibitors, and aldosterone antagonists have been shown to reduce hospitalizations, morbidity, and mortality in HFrEF while long-acting inhaled bronchodilators (beta-2-agonists and anticholinergics) and corticosteroids have been endorsed for COPD treatment. The opposing pharmacotherapy of BBs and beta-2-agonists highlight the conflict in prescribing BBs in COPD and beta-2-agonists in HFrEF. This has resulted in underutilization of evidence-based therapy for HFrEF in COPD patients owing to fear of adverse effects. This review aims to provide an update and current perspective on diagnostic and therapeutic management of patients wit...Continue Reading

References

Aug 26, 1998·The New England Journal of Medicine·S S GottliebR A Vogel
Apr 10, 1999·Respiratory Medicine·I DimopoulouG E Tzelepis
Jun 20, 2002·Journal of Cardiovascular Pharmacology·Tien M H NgRalph A Lugo
Jun 22, 2002·The Cochrane Database of Systematic Reviews·S S SalpeterC Cates
Dec 20, 2002·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Eugene KotlyarAllan R Glanville
Mar 5, 2003·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Peter A McCulloughUNKNOWN BNP Multinational Study Investigators
Feb 11, 2004·Chest·Brian K Gehlbach, Eugene Geppert
Jul 2, 2004·American Journal of Respiratory and Critical Care Medicine·Don D SinS F Paul Man
Nov 4, 2004·American Heart Journal·David H AuUNKNOWN ACQUIP Investigators
Mar 11, 2005·Canadian Journal of Physiology and Pharmacology·Don D Sin, S F Paul Man
May 17, 2006·Primary Care Respiratory Journal : Journal of the General Practice Airways Group·Houman Ashrafian, Andonis G Violaris
Jan 16, 2007·Journal of the American College of Cardiology·Thierry H Le JemtelSanja Jelic
Feb 22, 2007·Thorax·Lorcan P McGarveyUNKNOWN TORCH Clinical Endpoint Committee
Aug 4, 2007·American Journal of Respiratory and Critical Care Medicine·Stacey E AlexeeffJoel Schwartz
Sep 4, 2007·Lancet·Peter M A Calverley, Stephen I Rennard
Feb 2, 2008·The American Journal of Cardiology·Dan RusinaruChristophe Tribouilloy
Feb 26, 2008·American Heart Journal·Joana MascarenhasPaulo Bettencourt
Jun 21, 2008·American Journal of Respiratory and Critical Care Medicine·Yvette R B M van GestelDon Poldermans
Jan 27, 2009·European Journal of Heart Failure·Nathaniel Mark HawkinsJohn J V McMurray
May 16, 2009·Therapeutic Advances in Cardiovascular Disease·Angelo Maffei, Giuseppe Lembo
Dec 3, 2009·European Journal of Heart Failure·Nathaniel M HawkinsJohn J V McMurray
Apr 10, 2010·American Journal of Respiratory and Critical Care Medicine·Jose M MarinBartolome R Celli
Apr 24, 2010·Journal of the American College of Cardiology·Andrew JabbourChristopher S Hayward
May 26, 2010·Archives of Internal Medicine·Don D Sin, S F Paul Man
Sep 17, 2010·The New England Journal of Medicine·Theresa M MicheleSolomon Iyasu
May 21, 2011·Journal of the American College of Cardiology·Nathaniel M HawkinsJohn J V McMurray
Jun 28, 2011·The European Respiratory Journal·A MacchiaG Tognoni
Jul 7, 2011·Pulmonary Pharmacology & Therapeutics·Konstantinos BartziokasKonstantinos I Gourgoulianis

❮ Previous
Next ❯

Citations

Nov 30, 2018·The Cochrane Database of Systematic Reviews·Asmaa S AbdelhamidLee Hooper
Dec 7, 2018·The Cochrane Database of Systematic Reviews·Asmaa S AbdelhamidLee Hooper
Mar 3, 2020·The Cochrane Database of Systematic Reviews·Asmaa S AbdelhamidLee Hooper
Sep 18, 2020·European Heart Journal. Cardiovascular Pharmacotherapy·Seif El HadidiAndrew J S Coats
Jul 1, 2021·ESC Heart Failure·Yoshiaki KubotaUNKNOWN ASIAN-HF Executive Committee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.